series-b
Stage
1
Investors
About
PathogenDx develops a proprietary microarray-based diagnostic platform that enables rapid, multiplexed detection and quantitation of bacterial, fungal, and viral pathogens across clinical, food safety, and agricultural testing markets, including cannabis testing.
Explore PathogenDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.